Webinar: Immunotherapy for Patients with Operable Esophageal and GE Junction Adenocarcinoma
For more than four years, immunotherapy has been available as a first-line treatment for patients with Advanced and Metastatic [...]
Possible New Weapon to Fight Esophageal Cancer Magnifies Impact of Radiation on Tumors, Not Healthy Tissue
Late-stage clinical biotechnology company Nanobiotix announced promising first results of a Phase I study of the nanoradioenhancer NBTXR3 for [...]
Mindy Mintz Mordecai, Founder, President, and CEO of ECAN to Retire
Mindy Mintz Mordecai, Founder, President, and CEO of the Esophageal Cancer Action Network since 2009, will retire at the [...]
A Message from our Founder & CEO
ECAN has never been a job for me. It’s been my passion. Leading this movement to save lives has [...]
Historic Bill Passed by U.S. House of Representatives
In his final official act before Esophageal Cancer cut short his life, Congressman Gerald Connolly (D-Va) made history by [...]
A Message from our Founder
“Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only [...]
April is Esophageal Cancer Awareness Month!
ECAN is proud to have started Esophageal Cancer Awareness Month in 2009. We've been thrilled ever since by all [...]
Major Insurer Provides Coverage for PreCancer Screening
A First Step for Lucid, perhaps a Giant Leap for Patients at Risk for Esophageal Cancer! In what could [...]
Art Journaling for Patients & Caregivers
ECAN is offering Esophageal Cancer Patients & Caregivers a special course in Art Journaling. Art journaling is a [...]
Learn about the Latest Therapy Approved by the FDA for Gastroesophageal Cancer Patients
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On [...]